A clinical trial is any research study that evaluates interventions to prevent, detect, diagnose, or treat a disease or disorder. In a clinical trial, human participants (or groups of participants) are assigned to one or more interventions to assess the results on health outcomes.
Clinical Trials are important in discovering new treatments to prevent, detect, diagnose or treat Narcolepsy. It is the only process to bring new pharmacological drugs and treatments forward for approval to use within the Narcolepsy community. Without the clinical trials, there is a risk that individuals could be given treatments which have no advantage, waste time and could even be harmful to one’s health. If a treatment has no benefit, or has serious side effects, the treatment may not be further developed.
Falling asleep during the day? Sudden muscle weakness? Wake Up Narcolepsy is collaborating with Axsome Therapeutics on a study to assess the efficacy and safety of AXS-12 (Reboxetine) in patients with narcolepsy (SYMPHONY).
The research includes an MRI scan session and two (non-consecutive) overnight sleep sessions at our sleep laboratory in Montreal, Canada.
Scaling-out Better Nights, Better Days to help children and families go from surviving to thriving during COVID-19.
WUN is collaborating with Hypersomnia Foundation and Dr. Thanh Dang-Vu to investigate brain regions underlying narcolepsy (with or without cataplexy) and idiopathic hypersomnia.